Early occurence of hepatocellular carcinoma in patients with and without cirrhosis after HCV treatment with direct-acting antivirals

被引：0
|
作者：
Finkelmeier, F. [1 ]
Dultz, G. [2 ]
Kronenberger, B. [3 ]
Peiffer, K-H. [4 ]
Krauss, F. [2 ]
Zeuzem, S. [4 ]
Sarrazin, C. [5 ]
Vermehren, J. [6 ]
Waidmann, O. [4 ]
机构：
[1] Univ Klin Frankfurt Ukf, Gastroenterol, Frankfurt, Germany
[2] Uniklin Frankfurt, Frankfurt, Germany
[3] Herz Jesu Krankenhaus, Fulda, Germany
[4] Uniklin Frankfurt, Med Klin 1, Frankfurt, Germany
[5] Med Klin II, Gastroenterol, Wiesbaden, Germany
[6] Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
389
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [31] INCIDENCE OF HEPATOCELLULAR CARCINOMA AND EXTRAHEPATIC CANCERS AMONG HCV-INFECTED PATIENTS IN THE ERA OF DIRECT-ACTING ANTIVIRALS
    Wang, W.
    Lo Re, I. I. I., V
    Xiao, H.
    Brown, J.
    Yi, G.
    Park, H.
    VALUE IN HEALTH, 2018, 21 : S12 - S13
  • [32] Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals: comparative analysis with non-direct-acting antivirals-treated patients
    Abdelaziz, Ashraf O.
    Nabil, Mohamed M.
    Abdelmaksoud, Ahmed H.
    Shousha, Hend I.
    Hashem, Mohamed B.
    Hassan, Eman M.
    Salah, Ayman
    Omran, Dalia A.
    Elbaz, Tamer M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 75 - 79
  • [33] Direct-Acting Antivirals for HCV Treatment in Decompensated Liver Cirrhosis Patients: A Systematic Review and Meta-Analysis
    An, JiHyun
    Park, Dong Ah
    Ko, Min Jung
    Ahn, Sang Bong
    Yoo, Jeong-Ju
    Jun, Dae Won
    Yim, Sun Young
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (09):
  • [34] REDUCTION OF SPLENIC VOLUME AFTER DIRECT ACTING ANTIVIRALS TREATMENT IN PATIENTS WITH HCV COMPENSATED CIRRHOSIS
    Mihai, F.
    Cucuteanu, B.
    Lupascu-Ursulescu, Corina
    Negru, D.
    Sfarti, C.
    Cuciureanu, T.
    Cojocaru, Camelia
    Singeap, Ana-Maria
    Stanciu, C.
    Trifan, Anca
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2020, 124 (02): : 225 - 230
  • [35] Excellent effectiveness of direct-acting antivirals for HCV treatment in patients with cirrhosis: Analysis of 3345 patients from the Lombardia Network
    Degasperi, E.
    Pasulo, L.
    Aghemo, A.
    Puoti, M.
    Zaltron, S.
    Maggiolo, F.
    Rizzardini, G.
    Fargion, S.
    Sacchi, P.
    Gulminetti, R.
    Zuin, M.
    Quirino, T.
    Rumi, M. G.
    Pan, A.
    Grossi, P.
    Rossini, A.
    Corbellini, A.
    Foppa, C. Uberti
    Colli, A.
    Lampertico, P.
    Fagiuoli, S.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (01) : 38 - 38
  • [36] Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?
    Pol, Stanislas
    Vallet-Pichard, Anais
    Fontaine, Helene
    Carrat, Fabrice
    LIVER INTERNATIONAL, 2019, 39 (03) : 446 - 447
  • [37] Things fall apart with hepatocellular carcinoma and direct-acting antivirals
    Kutala, Blaise
    Valla, Dominique
    Marcellin, Patrick
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 107 - 109
  • [38] HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HCV RELATED CIRRHOSIS TREATED WITH DIRECT ACTING ANTIVIRALS: A SMOKING GUN OR GUILT BY ASSOCIATION?
    Ali, Bilal
    Imam, Mohamad
    Groeschell, Chip
    Patel, Kruti
    Gadiparthi, Chiranjeevi
    Gonzalez, Humberto C. Gonzalez
    Nair, Satheesh
    Satapathy, Sanjaya K.
    GASTROENTEROLOGY, 2017, 152 (05) : S1095 - S1096
  • [39] Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan
    Chi, Chen-Ta
    Chen, Chi-Yi
    Su, Chien-Wei
    Chen, Po-Yueh
    Chu, Chi-Jen
    Lan, Keng-Hsin
    Lee, I-Cheng
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2021, 54 (03) : 385 - 395
  • [40] Direct-acting antiviral treatment for patients with hepatocellular carcinoma
    Kushner, Tatyana
    Dieterich, Douglas
    Saberi, Behnam
    CURRENT OPINION IN GASTROENTEROLOGY, 2018, 34 (03) : 132 - 139
12345